Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) to Post FY2023 Earnings of ($2.24) Per Share, B. Riley Forecasts

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) – Equities research analysts at B. Riley issued their FY2023 earnings estimates for Longboard Pharmaceuticals in a research report issued to clients and investors on Wednesday, April 26th. B. Riley analyst K. Patel expects that the company will earn ($2.24) per share for the year. B. Riley has […]

Related Keywords

,Hedge Funds Weigh In On Longboard Pharmaceuticals ,Blackrock Inc ,Longboard Pharmaceuticals ,Longboard Pharmaceuticals Inc ,Longboard Pharmaceuticals Stock Down ,Bourgeon Capital Management ,Citigroup ,Nasdaq ,Health Asset Management ,News Ratings For Longboard Pharmaceuticals Daily ,Get Rating ,Longboard Pharmaceutical ,Pharmaceuticals Stock Down ,Capital Management ,Longboard Pharmaceuticals Daily ,Nasdaq Lbph ,Lbph ,Medical ,Earnings Estimates ,B Riley ,